Details on Sandoz Warning Letter Reveal Gaping Data Integrity Gaps

Drug GMP Report
On Tuesday, the FDA released the Oct. 22 warning letter issued to Sandoz sites in Kalwe and Turbhe, Maharashtra, India, which Sandoz had earlier hinted at during its third quarter earnings call. With the release of the warning letter, the extent of the data integrity issues are now known.

To View This Article:


Subscribe To Drug GMP Report